HLA‐A, B and DR in Caucasians with transitional cell carcinoma of the bladder

Abstract

When HLA-A, B and DR antigens in Caucasian patients with transitional cell carcinoma of the urinary bladder were compared with controls, no significant alterations in antigen frequencies were found.

Renal allograft outcomes following early corticosteroid withdrawal in Hispanic transplant recipients

“…We included only two groups in our analysis: Hispanic/Latino (n = 73) and white (non‐Hispanic/non‐Latino) (n = 146) recipients. HLA‐A, B, and DR phenotyping was performed using sera obtained from the NIH serum bank as previously described . The percentage of class I panel reactive antibodies (PRA) was measured by determining the patient serum reactivity against a panel of T cell‐enriched lymphocytes from the local patient/donor population.…”